Search research articles
Contact Us
Filters
Showing results (441-450 of 465) with videos related to
Page
of 47
Sort By:
Vaccine
|
June 21, 2022
Previous biological therapy and impairment of the IFN-γ/IL-10 axis are associated with low immune response to 17DD-YF vaccination in patients with spondyloarthritis
Thays Zanon Casagrande, Ismael Artur da Costa-Rocha, Maria Bernadete Renoldi de Oliveira Gavi, et al.
Human Vaccines & Immunotherapeutics
|
July 4, 2024
Hydroxychloroquine is associated with lower seroconversion upon 17DD-Yellow fever primovaccination in patients with primary Sjögren's syndrome
Ketty Lysie Libardi Lira Machado, Ismael Artur da Costa-Rocha, Laura Gonçalves Rodrigues Aguiar, et al.
Frontiers in Immunology
|
July 12, 2019
Duration of Humoral and Cellular Immunity 8 Years After Administration of Reduced Doses of the 17DD-Yellow Fever Vaccine
Ismael Artur da Costa-Rocha, Ana Carolina Campi-Azevedo, Vanessa Peruhype-Magalhães, et al.
Frontiers in Immunology
|
November 8, 2019
Corrigendum: Duration of Humoral and Cellular Immunity 8 Years After Administration of Reduced Doses of the 17DD-Yellow Fever Vaccine
Ismael Artur da Costa-Rocha, Ana Carolina Campi-Azevedo, Vanessa Peruhype-Magalhães, et al.
Viruses
|
July 29, 2023
Inactivated and Immunogenic SARS-CoV-2 for Safe Use in Immunoassays and as an Immunization Control for Non-Clinical Trials
Mariana Pierre de Barros Gomes, José Henrique Rezende Linhares, Tiago Pereira Dos Santos, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]
|
January 11, 2025
IL-17 as a putative hallmark of intense arthralgia and age-related serum immune mediator networks during acute chikungunya fever
Caio Wilker Teixeira, Jonai Pacheco Dias, Lizandra Morgado-Santos, et al.
Viruses
|
September 23, 2022
Protective Immunity of COVID-19 Vaccination with ChAdOx1 nCoV-19 Following Previous SARS-CoV-2 Infection: A Humoral and Cellular Investigation
Tamiris Azamor, Ingrid Siciliano Horbach, Danielle Brito E Cunha, et al.
BMC Infectious Diseases
|
July 16, 2014
Subdoses of 17DD yellow fever vaccine elicit equivalent virological/immunological kinetics timeline
Ana Carolina Campi-Azevedo, Paula de Almeida Estevam, Jordana Grazziela Coelho-Dos-Reis, et al.
Frontiers in Immunology
|
October 17, 2019
Short-Lived Immunity After 17DD Yellow Fever Single Dose Indicates That Booster Vaccination May Be Required to Guarantee Protective Immunity in Children
Ana Carolina Campi-Azevedo, Laise Rodrigues Reis, Vanessa Peruhype-Magalhães, et al.
Journal of Medical Primatology
|
November 21, 2020
Safety and immunogenicity of 17DD attenuated yellow fever vaccine in howler monkeys (Alouatta spp.)
André Tavares da Silva Fernandes, Silvia Bahadian Moreira, Luciane Pinto Gaspar, et al.
Page
of 47
Search research articles
Search
Showing results (441-450 of 465) with videos related to
Sort By:
Page
of 47
Vaccine
|
June 21, 2022
Previous biological therapy and impairment of the IFN-γ/IL-10 axis are associated with low immune response to 17DD-YF vaccination in patients with spondyloarthritis
Thays Zanon Casagrande, Ismael Artur da Costa-Rocha, Maria Bernadete Renoldi de Oliveira Gavi, et al.
Human Vaccines & Immunotherapeutics
|
July 4, 2024
Hydroxychloroquine is associated with lower seroconversion upon 17DD-Yellow fever primovaccination in patients with primary Sjögren's syndrome
Ketty Lysie Libardi Lira Machado, Ismael Artur da Costa-Rocha, Laura Gonçalves Rodrigues Aguiar, et al.
Frontiers in Immunology
|
July 12, 2019
Duration of Humoral and Cellular Immunity 8 Years After Administration of Reduced Doses of the 17DD-Yellow Fever Vaccine
Ismael Artur da Costa-Rocha, Ana Carolina Campi-Azevedo, Vanessa Peruhype-Magalhães, et al.
Frontiers in Immunology
|
November 8, 2019
Corrigendum: Duration of Humoral and Cellular Immunity 8 Years After Administration of Reduced Doses of the 17DD-Yellow Fever Vaccine
Ismael Artur da Costa-Rocha, Ana Carolina Campi-Azevedo, Vanessa Peruhype-Magalhães, et al.
Viruses
|
July 29, 2023
Inactivated and Immunogenic SARS-CoV-2 for Safe Use in Immunoassays and as an Immunization Control for Non-Clinical Trials
Mariana Pierre de Barros Gomes, José Henrique Rezende Linhares, Tiago Pereira Dos Santos, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]
|
January 11, 2025
IL-17 as a putative hallmark of intense arthralgia and age-related serum immune mediator networks during acute chikungunya fever
Caio Wilker Teixeira, Jonai Pacheco Dias, Lizandra Morgado-Santos, et al.
Viruses
|
September 23, 2022
Protective Immunity of COVID-19 Vaccination with ChAdOx1 nCoV-19 Following Previous SARS-CoV-2 Infection: A Humoral and Cellular Investigation
Tamiris Azamor, Ingrid Siciliano Horbach, Danielle Brito E Cunha, et al.
BMC Infectious Diseases
|
July 16, 2014
Subdoses of 17DD yellow fever vaccine elicit equivalent virological/immunological kinetics timeline
Ana Carolina Campi-Azevedo, Paula de Almeida Estevam, Jordana Grazziela Coelho-Dos-Reis, et al.
Frontiers in Immunology
|
October 17, 2019
Short-Lived Immunity After 17DD Yellow Fever Single Dose Indicates That Booster Vaccination May Be Required to Guarantee Protective Immunity in Children
Ana Carolina Campi-Azevedo, Laise Rodrigues Reis, Vanessa Peruhype-Magalhães, et al.
Journal of Medical Primatology
|
November 21, 2020
Safety and immunogenicity of 17DD attenuated yellow fever vaccine in howler monkeys (Alouatta spp.)
André Tavares da Silva Fernandes, Silvia Bahadian Moreira, Luciane Pinto Gaspar, et al.
Page
of 47